Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins
- PMID: 7526103
- DOI: 10.1016/s0140-6736(94)90290-9
Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins
Abstract
CD44 variants containing v6 confer metastatic potential to rat carcinoma cell-lines. In man, CD44v6 is increasingly expressed during colorectal tumour progression. In 68 colorectal carcinoma patients, survival analysis showed that CD44v6 expression in the tumours was associated with tumour-related death. In patients who had an apparently radical resection of their primary tumour, CD44v6 expression had prognostic value independent of Dukes' stage. CD44v6 expression may reflect propensity for metastasis after apparently curative surgery, making adjuvant therapy an option in these patients.
Comment in
-
Effect of CD44v6 on survival in colorectal carcinoma.Lancet. 1995 Feb 4;345(8945):327-8. doi: 10.1016/s0140-6736(95)90320-8. Lancet. 1995. PMID: 7530795 No abstract available.
-
Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.Lancet. 1995 Mar 4;345(8949):583. Lancet. 1995. PMID: 7539876 No abstract available.
-
Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.Lancet. 1995 Mar 4;345(8949):583-4. Lancet. 1995. PMID: 7539877 No abstract available.
Similar articles
-
Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.Lancet. 1995 Mar 4;345(8949):583-4. Lancet. 1995. PMID: 7539877 No abstract available.
-
CD44 variant exon epitopes in primary breast cancer and length of survival.Lancet. 1995 Mar 11;345(8950):615-9. doi: 10.1016/s0140-6736(95)90521-9. Lancet. 1995. PMID: 7534855
-
CD44 splice variants as prognostic markers in colorectal cancer.Scand J Gastroenterol. 1998 Jan;33(1):82-7. doi: 10.1080/00365529850166257. Scand J Gastroenterol. 1998. PMID: 9489913
-
CD44 in colon cancer.Eur J Cancer. 1995 Jul-Aug;31A(7-8):1110-2. doi: 10.1016/0959-8049(95)00252-e. Eur J Cancer. 1995. PMID: 7577002 Review.
-
CD44v6 engages in colorectal cancer progression.Cell Death Dis. 2019 Jan 10;10(1):30. doi: 10.1038/s41419-018-1265-7. Cell Death Dis. 2019. PMID: 30631039 Free PMC article. Review.
Cited by
-
NANOG modulates stemness in human colorectal cancer.Oncogene. 2013 Sep 12;32(37):4397-405. doi: 10.1038/onc.2012.461. Epub 2012 Oct 22. Oncogene. 2013. PMID: 23085761 Free PMC article.
-
Epithelial calcineurin controls microbiota-dependent intestinal tumor development.Nat Med. 2016 May;22(5):506-15. doi: 10.1038/nm.4072. Epub 2016 Apr 4. Nat Med. 2016. PMID: 27043494 Free PMC article.
-
Increased expression of CD44v6 in endocrine pancreatic tumours but not in midgut carcinoid tumours.Clin Mol Pathol. 1996 Aug;49(4):M203-8. doi: 10.1136/mp.49.4.m203. Clin Mol Pathol. 1996. PMID: 16696075 Free PMC article.
-
Overexpression of CBS/H2S inhibits proliferation and metastasis of colon cancer cells through downregulation of CD44.Cancer Cell Int. 2022 Feb 16;22(1):85. doi: 10.1186/s12935-022-02512-2. Cancer Cell Int. 2022. PMID: 35172821 Free PMC article.
-
Don't sugarcoat it: How glycocalyx composition influences cancer progression.J Cell Biol. 2020 Jan 6;219(1):e201910070. doi: 10.1083/jcb.201910070. J Cell Biol. 2020. PMID: 31874115 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous